02196 FOSUN PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 0.92X | Oper Margin | 9.7% |
|---|---|---|---|
| LT Debt/Equity | 27.5% | Net Margin | 6.8% |
| Total Debt/Equity | 76.1% | Return on Equity | 5.9% |
| Price/Book | 0.96X | Return on Assets | 2.4% |
| (HKD 18.120) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 2,945.77 | 2,643.74 | 4,189.90 | 5,783.69 | 4,347.03 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +11.4 | -36.9 | -27.6 | +33.1 | +17.1 |
| Earnings Per Share (HKD) | 1.103 | 0.99 | 1.607 | 2.257 | 1.696 |
| Earnings Per Share Growth (%) | +11.4 | -38.4 | -28.8 | +33.1 | +17.1 |
| Dividend Per Share (HKD) | 0.350 | 0.300 | 0.460 | 0.660 | 0.520 |
| P/E* (X) | 16.43 | 18.30 | 11.28 | 8.03 | 10.68 |
| Yield (%) | 1.93 | 1.66 | 2.54 | 3.64 | 2.87 |
| Dividend Share (%) | 31.73 | 30.29 | 28.63 | 29.25 | 30.66 |
| Book NAV (HKD) | 18.894 | 18.826 | 18.685 | 18.678 | 17.105 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 40,910 | 41,249 | -0.8 | 43,811 |
| Operating Result | 1,515 | 375.896 | +303.0 | 2,264 |
| Associates | 1,644 | 2,185 | -24.8 | 1,835 |
| Profit Before Taxation | 4,169 | 3,277 | +27.2 | 4,581 |
| Taxation | 656.841 | 369.504 | +77.8 | 626.918 |
| Profit /( Loss) After Taxation | 3,512 | 2,907 | +20.8 | 3,954 |
| Minority Interests | 742.554 | 508.798 | +45.9 | 216.659 |
| Net Profit | 2,770 | 2,399 | +15.5 | 3,737 |
| Earnings Per Share () | 1.1031 | 0.9903 | +11.4 | 1.6069 |
| Dividend Per Share () | 0.3500 | 0.3000 | +16.7 | 0.4600 |
| Announcement Date | 2025-03-25 | 2024-03-26 | NA | 2023-03-27 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
